Achmea Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-309
Closed -$44K 606
2023
Q2
$44K Hold
309
﹤0.01% 575
2023
Q1
$52K Hold
309
﹤0.01% 527
2022
Q4
$49K Buy
+309
New +$56K ﹤0.01% 568

Other funds holding RGEN

Achmea Investment Management's RGEN Position: Q3 2023 in Review

Achmea Investment Management sold out of Repligen (RGEN) in Q3 2023, closing a stake of 309 shares — an estimated $44K sold.

Achmea Investment Management first reported a position in RGEN in Q4 2022 and held it in 3 quarters. The position peaked at $52K in Q1 2023. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Achmea Investment Management reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Achmea Investment Management sold 309 Repligen shares in Q3 2023, an estimated $44K.
  • Achmea Investment Management first reported a position in Repligen in Q4 2022 and held it in 3 quarters.
  • Achmea Investment Management's Repligen position peaked at $52K in Q1 2023.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Achmea Investment Management's 13F filing for Q3 2023, filed 6 Nov 2023.